Shouguang Fukang Pharmaceutical Co. Ltd Sustainability Profile
Shouguang Fukang Pharmaceutical Co. Ltd., a prominent player in the pharmaceutical industry, is headquartered in Shouguang, China. Established in 1998, the company has made significant strides in the development and production of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong focus on research and innovation, Shouguang Fukang has developed a diverse portfolio that includes both generic and proprietary drugs, setting itself apart through rigorous quality control and adherence to international standards. The company has earned a solid market position, recognised for its commitment to excellence and customer satisfaction. Operating primarily in Asia, Shouguang Fukang continues to expand its reach, contributing to the global healthcare landscape with its unique offerings and dedication to improving patient outcomes.
DitchCarbon Score
How does Shouguang Fukang Pharmaceutical Co. Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shouguang Fukang Pharmaceutical Co. Ltd's score of 21 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shouguang Fukang Pharmaceutical Co. Ltd's reported carbon emissions
Shouguang Fukang Pharmaceutical Co. Ltd, headquartered in China (CN), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. Additionally, the company has not established any formal reduction targets or climate pledges, which suggests a lack of publicly available commitments towards carbon neutrality or emissions reduction initiatives. As there is no data inherited from a parent company or related organisation, all information is based solely on Shouguang Fukang Pharmaceutical Co. Ltd's own disclosures. The absence of emissions data and reduction initiatives highlights a potential area for improvement in their environmental strategy and transparency.
How Carbon Intensive is Shouguang Fukang Pharmaceutical Co. Ltd's Industry?
How Carbon Intensive is Shouguang Fukang Pharmaceutical Co. Ltd's Location?
Shouguang Fukang Pharmaceutical Co. Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shouguang Fukang Pharmaceutical Co. Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
